ProfileGDS4718 / 1566472_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 91% 44% 81% 85% 68% 43% 89% 91% 83% 89% 83% 76% 49% 67% 79% 85% 73% 61% 50% 89% 89% 85% 84% 81% 70% 90% 39% 80% 64% 76% 59% 89% 90% 58% 26% 64% 84% 91% 49% 93% 37% 18% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.978888
GSM549102patient 115, normal, homogenized [OPG study]9.2798491
GSM549104patient 119, normal, homogenized [OPG study]5.1856944
GSM549108patient 138, normal, homogenized [OPG study]7.9163681
GSM549119patient 077, normal, homogenized [OPG study]8.3555685
GSM549133patient 032, cancer, homogenized [OPG study]6.7792168
GSM549139patient 042, cancer, homogenized [OPG study]5.122443
GSM549099patient 107, normal, homogenized [OPG study]8.9799689
GSM549109patient 139, normal, homogenized [OPG study]9.4381591
GSM549110patient 046, normal, homogenized [OPG study]8.2022383
GSM549114patient 063, normal, homogenized [OPG study]9.2166889
GSM549122patient 082, normal, homogenized [OPG study]8.1460883
GSM549134patient 033, cancer, homogenized [OPG study]7.4143476
GSM549136patient 036, cancer, homogenized [OPG study]5.4210749
GSM549140patient 044, cancer, homogenized [OPG study]6.6293167
GSM549111patient 047, normal, homogenized [OPG study]7.836379
GSM549113patient 057, normal, homogenized [OPG study]8.5849985
GSM549132patient 031, cancer, homogenized [OPG study]7.1840573
GSM549137patient 038, cancer, homogenized [OPG study]6.2182361
GSM549142patient 047, cancer, homogenized [OPG study]5.6187950
GSM549100patient 110, normal, homogenized [OPG study]9.0144489
GSM549107patient 135, normal, homogenized [OPG study]9.0631989
GSM549115patient 068, normal, homogenized [OPG study]8.6813785
GSM549116patient 072, normal, homogenized [OPG study]8.342484
GSM549120patient 078, normal, homogenized [OPG study]8.0068881
GSM549131patient 030, cancer, homogenized [OPG study]6.8953670
GSM549118patient 074, normal, homogenized [OPG study]9.3406790
GSM549129patient 027, cancer, homogenized [OPG study]4.939739
GSM549123patient 088, normal, homogenized [OPG study]7.8430480
GSM549124patient 006, cancer, homogenized [OPG study]6.4091864
GSM549126patient 015, cancer, homogenized [OPG study]7.4081176
GSM549128patient 025, cancer, homogenized [OPG study]6.1004559
GSM549103patient 117, normal, homogenized [OPG study]9.0052789
GSM549117patient 073, normal, homogenized [OPG study]9.3066290
GSM549138patient 041, cancer, homogenized [OPG study]5.9782958
GSM549141patient 045, cancer, homogenized [OPG study]4.3208126
GSM549130patient 028, cancer, homogenized [OPG study]6.3640864
GSM549101patient 111, normal, homogenized [OPG study]8.3294284
GSM549105patient 128, normal, homogenized [OPG study]9.3628991
GSM549106patient 134, normal, homogenized [OPG study]5.4194949
GSM549112patient 048, normal, homogenized [OPG study]9.8845693
GSM549125patient 011, cancer, homogenized [OPG study]4.8389437
GSM549127patient 024, cancer, homogenized [OPG study]4.0584918
GSM549135patient 035, cancer, homogenized [OPG study]5.5416651